LRRC2

Chr 3

leucine rich repeat containing 2

This gene encodes a leucine-rich repeat-containing protein that may function as a tumor suppressor and is possibly localized to the nucleus. Mutations in LRRC2 cause autosomal recessive primary ciliary dyskinesia, a disorder affecting respiratory cilia function that leads to chronic respiratory infections, bronchiectasis, and often situs inversus. The gene shows minimal constraint against loss-of-function variants (very low pLI score), which is consistent with autosomal recessive inheritance where heterozygous carriers are typically unaffected.

OMIMResearchSummary from RefSeq
MultiplemechanismLOEUF 1.14
Clinical SummaryLRRC2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
8 unique Pathogenic / Likely Pathogenic· 53 VUS of 72 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.14LOEUF
pLI 0.000
Z-score 1.12
OE 0.71 (0.451.14)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.93Z-score
OE missense 0.81 (0.720.93)
162 obs / 199.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.71 (0.451.14)
00.351.4
Missense OE0.81 (0.720.93)
00.61.4
Synonymous OE1.12
01.21.6
LoF obs/exp: 12 / 17.0Missense obs/exp: 162 / 199.0Syn Z: -0.85
DN
0.6937th %ile
GOF
0.82top 10%
LOF
0.2871th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

72 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic1
VUS53
Benign4
7
Pathogenic
1
Likely Pathogenic
53
VUS
4
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
7
0
7
Likely Pathogenic
0
0
1
0
1
VUS
0
52
1
0
53
Likely Benign
0
0
0
0
0
Benign
0
4
0
0
4
Total0569065

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

LRRC2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC